EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 41 filers reported holding EVOGENE LTD in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,903 | -37.8% | 50,985 | +13.4% | 0.00% | -50.0% |
| Q2 2023 | $48,090 | +65.9% | 44,944 | -2.3% | 0.00% | +100.0% |
| Q1 2023 | $28,980 | -8.7% | 46,000 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $31,754 | -16.4% | 45,363 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $38,000 | +58.3% | 45,363 | +42.6% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -41.5% | 31,810 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $41,000 | +51.9% | 31,410 | +88.0% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | -49.1% | 16,710 | -16.9% | 0.00% | -50.0% |
| Q3 2021 | $53,000 | -38.4% | 20,110 | -19.9% | 0.00% | -33.3% |
| Q2 2021 | $86,000 | -33.3% | 25,110 | -1.6% | 0.00% | -25.0% |
| Q1 2021 | $129,000 | +130.4% | 25,510 | +112.4% | 0.00% | +100.0% |
| Q4 2020 | $56,000 | – | 12,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 293,057 | $481,000 | 0.20% |
| Eidelman Virant Capital | 113,000 | $185,000 | 0.07% |
| Susquehanna International Group Ltd. | 31,753 | $55,000 | 0.02% |
| ARK Investment Management | 3,611,842 | $6,020,000 | 0.02% |
| Senvest Management, LLC | 230,606 | $378,000 | 0.01% |
| Csenge Advisory Group | 28,700 | $96,000 | 0.01% |
| MGO ONE SEVEN LLC | 25,340 | $42,000 | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 25,826 | $42,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $16,000 | 0.00% |
| Vident Investment Advisory, LLC | 49,786 | $82,000 | 0.00% |